Fiji Business Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Fiji Business Review.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on December 7, 2025

Dec. 7, 2025

Immix Biopharma Announces Pricing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire

$At ASH 2025 Oral Presentation, Immix Biopharma Reports Positive Phase 2 NXC-201 Results, Advancing Toward BLA Submission as a Potentially First- and Best-in-Class Therapy for relapsed/refractory AL Amyloidosis$

Dec. 7, 2025

At ASH 2025 Oral Presentation, Immix Biopharma Reports Positive Phase 2 NXC-201 Results, Advancing Toward BLA Submission as a Potentially First- and Best-in-Class Therapy for relapsed/refractory AL Amyloidosis

GlobeNewswire

Dec. 7, 2025

Lime & Lemon Apex Redefines the Dining Scene with an Experience the Triangle Was Waiting For

GlobeNewswire

Dec. 7, 2025

ImCheck Reports Durable Responses and Early Overall Survival Signal with ICT01 in First-line AML at ASH 2025

GlobeNewswire

Dec. 7, 2025

Drilling hits wide zone of mineralisation in new area well outside resource

GlobeNewswire

Dec. 7, 2025

Les forages recoupent une large zone minéralisée dans un nouveau secteur bien en dehors des ressources

GlobeNewswire

Dec. 7, 2025

Former National Security Analyst Signals a Warning in Recent Presentation: “Most Americans are completely uninformed about China’s ambition and power.”

GlobeNewswire

Dec. 7, 2025

Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and Exposition

GlobeNewswire

Dec. 7, 2025

CAPHRA Raises Alarm over Legitimacy of WHO Tobacco Treaty.

GlobeNewswire

Dec. 7, 2025

WPP INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that WPP plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire

Dec. 7, 2025

MRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Marex Group plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire

Dec. 7, 2025

Dyne Therapeutics to Host Investor Conference Call and Webcast to Review Topline Results from Registrational Expansion Cohort (REC) of DELIVER Clinical Trial of Z-Rostudirsen (DYNE-251) in Duchenne Muscular Dystrophy; Tomorrow, December 8 at 8:00 a.m. ET

GlobeNewswire

Dec. 7, 2025

Kessler Topaz Meltzer & Check, LLP Reminds StubHub Holdings, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit

GlobeNewswire

Dec. 7, 2025

Nayax Considering an Offering of Notes and Warrants in Israel

GlobeNewswire

Dec. 7, 2025

Real Estate Expert Kerry Ramage of Melbourne, FL, Breaks Down Home Sale Strategy for HelloNation

GlobeNewswire

Dec. 7, 2025

Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease

GlobeNewswire

Dec. 7, 2025

ALX Oncology Announces Positive Results from Ongoing Investigator-Sponsored Phase 2 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with Indolent B-cell Non-Hodgkin Lymphoma, at ASH Annual Meeting

GlobeNewswire

Dec. 7, 2025

Mutuum Finance (MUTM) Approaches 100% Presale Sellout Amid Ongoing Halborn Security Review

GlobeNewswire

Dec. 7, 2025

Manufacturing Expert James Gizzi of Rochester Discusses How to Choose a CNC Machine Shop in HelloNation

GlobeNewswire

Dec. 7, 2025

How Roofing Expert Tom Meadows of Ann Arbor Explains Roof Repair vs. Roof Replacement for HelloNation

GlobeNewswire